Cosmos Health Stock to Reverse Split on Friday, November 13th (NASDAQ:COSM)

Cosmos Health Inc. (NASDAQ:COSM) shares are set to reverse split before the market opens on Friday, November 13th. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, November 11th.

Cosmos Health Price Performance

NASDAQ:COSM traded down $0.03 during mid-day trading on Thursday, reaching $0.21. 1,838,616 shares of the company were exchanged, compared to its average volume of 4,088,889. Cosmos Health has a 12 month low of $0.16 and a 12 month high of $0.77. The company has a quick ratio of 0.92, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The company has a fifty day moving average of $0.31 and a 200 day moving average of $0.30. The stock has a market cap of $21.23 million, a PE ratio of -0.33 and a beta of 4.73.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings data on Tuesday, August 18th. The company reported ($0.10) EPS for the quarter, hitting analysts’ consensus estimates of ($0.10). The firm had revenue of $19.32 million during the quarter, compared to analyst estimates of $18.99 million. Cosmos Health had a negative return on equity of 56.88% and a negative net margin of 33.08%. On average, research analysts anticipate that Cosmos Health will post -0.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Noble Financial began coverage on shares of Cosmos Health in a research report on Monday, October 26th. They issued an “outperform” rating for the company. Weiss Ratings restated a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, October 28th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Cosmos Health presently has an average rating of “Hold”.

Institutional Investors Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Renaissance Technologies LLC grew its stake in Cosmos Health Inc. (NASDAQ:COSM) by 16.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 390,500 shares of the company’s stock after purchasing an additional 55,925 shares during the quarter. Renaissance Technologies LLC owned approximately 0.75% of Cosmos Health worth $124,000 as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors and hedge funds.

About Cosmos Health

Cosmos Health Inc. is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels. The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.